BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17358)

  • 1. The effects of psychopharmacological agents on central nervous system amine metabolism in man.
    Maas JW
    Annu Rev Pharmacol Toxicol; 1977; 17():411-24. PubMed ID: 17358
    [No Abstract]   [Full Text] [Related]  

  • 2. Amine metabolites in the cerebrospinal fluid as a measure of central neurotransmitter function: methodological aspects.
    Bertilsson L; Asberg M
    Adv Biochem Psychopharmacol; 1984; 39():27-34. PubMed ID: 6205559
    [No Abstract]   [Full Text] [Related]  

  • 3. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M
    Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biogenic amine metabolism in Tourette syndrome.
    Butler IJ; Koslow SH; Seifert WE; Caprioli RM; Singer HS
    Ann Neurol; 1979 Jul; 6(1):37-9. PubMed ID: 292354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in the CSF levels of monoamine metabolites in 102 chronic schizophrenic patients following probenecid before and after neuroleptic medication].
    Chen YF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1984 Oct; 17(5):273-7. PubMed ID: 6085683
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical evidence for neurochemical adaptation to psychotropic drugs.
    Goodwin FK; Post RM; Sack RL
    Adv Biochem Psychopharmacol; 1975; 13():33-45. PubMed ID: 239532
    [No Abstract]   [Full Text] [Related]  

  • 7. Amine metabolites in cerebrospinal fluid from Huntigton's chorea patients treated with lithium.
    Vestergaard P; Yates CM
    Clin Chim Acta; 1978 Jul; 87(2):297-9. PubMed ID: 148982
    [No Abstract]   [Full Text] [Related]  

  • 8. [The probenecid test and its application to research in schizophrenia].
    Chen YF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1984 Aug; 17(4):252-5. PubMed ID: 6085620
    [No Abstract]   [Full Text] [Related]  

  • 9. Monoamine metabolites as indicators of the effect of centrally acting drugs on monoamine release in rat brain.
    Karasawa T; Furukawa K; Ochi Y; Shimizu M
    Arch Int Pharmacodyn Ther; 1978 Feb; 231(2):261-73. PubMed ID: 646524
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drugs acting on the central nervous system].
    Recenti Prog Med; 1982 Oct; 73(4):462-478. PubMed ID: 6130574
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of psychoactive drugs on cyclic nucleotides in the central nervous system.
    Palmer GC
    Prog Neurobiol; 1983; 21(1-2):1-133. PubMed ID: 6140706
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of drugs on amines in the CNS.
    Sulser F; Sanders-Bush E
    Annu Rev Pharmacol; 1971; 11():209-30. PubMed ID: 4948498
    [No Abstract]   [Full Text] [Related]  

  • 13. [Amine metabolites in cerebrospinal fluids and thyrotropin releasing hormone in spinocerebellar degeneration].
    Arai M
    Rinsho Shinkeigaku; 1988 Jun; 28(6):595-604. PubMed ID: 2466598
    [No Abstract]   [Full Text] [Related]  

  • 14. Biogenic amine metabolites in cerebrospinal fluid of patients with affective disorders.
    Vestergaard P; Sørensen T; Hoppe E; Rafaelsen OJ; Yates CM; Nicolaou N
    Acta Psychiatr Scand; 1978 Jul; 58(1):88-96. PubMed ID: 696380
    [No Abstract]   [Full Text] [Related]  

  • 15. Central nervous system catecholamine metabolism in Korsakoff's psychosis.
    Martin PR; Weingartner H; Gordon EK; Burns RS; Linnoila M; Kopin IJ; Ebert MH
    Ann Neurol; 1984 Feb; 15(2):184-7. PubMed ID: 6200058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biogenic amine and metabolite levels in depressed patients with high versus normal hypothalamic-pituitary-adrenocortical activity.
    Stokes PE; Maas JW; Davis JM; Koslow SH; Casper RC; Stoll PM
    Am J Psychiatry; 1987 Jul; 144(7):868-72. PubMed ID: 2440319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A perspective: psychopharmacological aspects of aggression in animals and man.
    Singhal RL; Telner JI
    Psychiatr J Univ Ott; 1983 Sep; 8(3):145-53. PubMed ID: 6139834
    [No Abstract]   [Full Text] [Related]  

  • 18. Simultaneous determination of the three major monoamine metabolites in CSF by HPLC with electrochemical detection.
    Van Bockstaele M; Dillen L; Claeys M; De Potter WP
    Arch Int Pharmacodyn Ther; 1982 Dec; 260(2):304-5. PubMed ID: 6187306
    [No Abstract]   [Full Text] [Related]  

  • 19. CSF monoamine metabolites, depression, and suicide.
    Asberg M; Bertilsson L; MÃ¥rtensson B
    Adv Biochem Psychopharmacol; 1984; 39():87-97. PubMed ID: 6205566
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlations between height of subject and concentrations of monoamine metabolites in cerebrospinal fluid from psychotic men and women.
    Wode-Helgodt B; Sedvall G
    Commun Psychopharmacol; 1978; 2(2):177-83. PubMed ID: 668302
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.